Sacubitril/valsartan in heart failure: Differing added benefit
Due to a subgroup effect, reviewers have found that there is an indication of a minor added benefit for patients with diabetes, and an indication of a considerable added benefit for patients without diabetes, when using Sacubitril/valsartan in heart failure.
Leave a Reply